{"TopicDetails": {"type": 0, "ccm2Id": 46650103, "cftId": 0, "identifier": "HORIZON-JU-IHI-2024-06-02-two-stage", "title": "Development of evidence based practical guidance for sponsors on the use of real-world data / real-world evidence", "publicationDateLong": 1705363200000, "callIdentifier": "HORIZON-JU-IHI-2024-06-two-stage", "callTitle": "Innovative Health Initiative JU Call 6", "callccm2Id": 46650108, "allowPartnerSearch": true, "frameworkProgramme": {"id": 43108390, "abbreviation": "HORIZON", "description": "Horizon Europe Framework Programme (HORIZON)"}, "programmeDivision": [{"id": 45177852, "abbreviation": "HORIZON.2.1.7", "description": "Innovative Health Initiative"}, {"id": 43108557, "abbreviation": "HORIZON.2.1", "description": "Health"}, {"id": 43108541, "abbreviation": "HORIZON.2", "description": "Global Challenges and European Industrial Competitiveness"}], "topicMGAs": [], "tags": ["Joint Undertaking", "Innovative Health Initiative", "Innovative Health Initiative Joint Undertaking", "Development of evidence based practical guidance for sponsors on the use of real-world data / real-world evidence", "IHI JU", "IHI"], "keywords": ["Health outcomes", "Regulatory affairs", "Epigenetics and gene regulation", "Health data", "Health technology assessment"], "sme": false, "actions": [{"status": {"id": 31094503, "abbreviation": "Closed", "description": "Closed"}, "types": [{"typeOfAction": "HORIZON-JU-RIA HORIZON JU Research and Innovation Actions", "typeOfMGA": [{"id": 43027846, "abbreviation": "HORIZON-AG", "description": "HORIZON Action Grant Budget-Based"}]}], "plannedOpeningDate": "16 January 2024", "submissionProcedure": {"id": 31094505, "abbreviation": "two-stage", "description": "two-stage"}, "deadlineDates": ["16 April 2024", "10 October 2024"]}], "latestInfos": [], "budgetOverviewJSONItem": {"budgetTopicActionMap": {"3531597": [{"action": "HORIZON-JU-IHI-2024-06-02-two-stage - HORIZON-JU-RIA HORIZON JU Research and Innovation Actions", "plannedOpeningDate": "16 January 2024", "deadlineModel": "two-stage", "deadlineDates": ["16 April 2024", "10 October 2024"], "budgetYearMap": {"2023": 24600000}, "expectedGrants": 1, "minContribution": 13300000, "maxContribution": 13300000, "budgetTopicActionMap": {}}, {"action": "HORIZON-JU-IHI-2024-06-01-two-stage - HORIZON-JU-RIA HORIZON JU Research and Innovation Actions", "plannedOpeningDate": "16 January 2024", "deadlineModel": "two-stage", "deadlineDates": ["16 April 2024", "10 October 2024"], "budgetYearMap": {"2023": 24600000}, "expectedGrants": 1, "minContribution": 11300000, "maxContribution": 11300000, "budgetTopicActionMap": {}}]}, "budgetYearsColumns": ["2023"]}, "description": "<SPAN class=\"topicdescriptionkind\">ExpectedOutcome</SPAN>:<ul level=\"0\"><li>Industry, sponsors, and other stakeholders have access to structured, evidence-based and practical guidance and recommendations on the use of real-world data / real world evidence (RWD/RWE)<sup>1 </sup>that could be followed to support the development, and regulatory, health technologies assessment (HTA), and payer decision-making of innovative medicines and health technologies with a focus on medicinal products, medical devices, and therapeutic products that combine a medicinal product with a medical device (drug-device combinations).</li><li>Regulators, HTA bodies and payers will receive more structured and consistent RWD/RWE submissions to inform their decision making.</li> </ul><p><sup>1</sup> <sub>Real World Data (RWD) are defined as \u201croutinely collected data relating to a patient's health status or the delivery of health care from a variety of sources other than traditional clinical trials.\u201d Real-world evidence (RWE) is defined as the information derived from analysis of RWD. <a href=\"http://doi.org/10.1002/cpt.1426\">https://doi.org/10.1002/cpt.1426</a></sub></p>\n<SPAN class=\"topicdescriptionkind\">Scope</SPAN>:<p>The use of real-world evidence to support decision making on the safety of medicinal products is already well established. More recently, RWE has also been used to complement evidence and support marketing authorisation, conformity assessments and HTA submissions. While high-level guidance on the use of RWD/RWE exists, the practical implementation is left up to individual sponsors. Currently, RWD/RWE submissions are usually custom-made to a specific use-case and require significant expertise and effort from the sponsor to prepare, and from the healthcare decision-maker to assess. Much knowledge exists within individual sponsors on these use-cases, but, to date, this has not been leveraged to develop practical guidance which could act as a baseline for future submissions.</p><p>To leverage the learning from individual use cases and facilitate the efficient use of RWD/RWE for regulatory, HTA, and payer submissions and to inform healthcare decision-making, structured, evidence-based, and practical guidance is needed.</p><p>To address this challenge, the action funded under this topic should:</p><ul level=\"0\"><li>Map relevant RWD/RWE initiatives across Europe and their (expected) outcomes. Where relevant, build on, align, and complement these initiatives, including the European Medicines Agency\u2019s vision to establish the value of RWE across the spectrum of regulatory use cases by 2025<strong> </strong><sup>1</sup><strong>.</strong></li><li>Identify the main challenges faced by industry, sponsors, non-commercial sponsors, health professionals, prescribers, and other stakeholders in the routine use of RWD/RWE for regulatory and HTA decision-making. This is to be done by also taking into account the differences in the regulatory frameworks of medicinal products and medical devices and how stakeholders\u2019 experiences, needs, and situations are reflected in these.</li><li>In collaboration with the relevant stakeholders, identify, review, and evaluate existing methodologies, guidelines, and practices for the use of RWD/RWE in healthcare decision-making.</li><li>Focus on an in-depth study of a broad range of use cases where RWD/RWE has been previously assessed for decision-making for medicinal products, medical devices, and combinations. This should include an analysis of methods, designs, and defining variables that enable the grouping and thereafter the utilisation of RWD/RWE sources. Particular attention should be paid to the features that enable efficient assessments.</li><li>Using the results of the study as a foundation, develop a draft of the practical guidance document and recommendations on the use of RWD/RWE to support submissions and decision-making processes, taking into consideration the specific needs of medicinal products and medical devices. Considerations on how RWD/RWE can be used within an ethical framework and respects EU values should be included. In addition, ensure that the guidance respects the EU data quality framework and the relevant RWD specialisation (which is currently under development).</li><li>Test the draft guidance in several pilots to ensure validity and broad acceptability.The precise scope of these pilots should be selected by the full consortium during preparation of the full proposal and should address multiple contexts and areas that are not already being addressed, including but not limited to: chronic serious diseases, oncology, and auto-immune diseases. They should also cover clinical development and the regulatory, HTA, and payer assessment of medicinal products and medical devices including combinations.</li><li>Based on the learnings from the pilots, finalise the practical guidance document and recommendations on the use of RWD/RWE to support clinical development, regulatory, HTA and payer submissions and inform decision-making processes.</li><li>Broadly disseminate the guidance and recommendations to the stakeholder community. Create training plans to enable dissemination.</li> </ul><p>Applicants should develop a strategy and plan for generating appropriate evidence as well as for engaging and formally consulting with regulators, HTA agencies and payers in a timely manner, in particular on the draft guidance (e.g. through national competent authorities, the EMA Innovation Task Force, qualification advice).</p><p>In addition, while the project will focus on supporting the development of a recommendation for a structured, practical and evidence based guidance, the funded project is also expected to explore synergies with complementary initiatives to advance RWD/RWD in Europe such as the GetReal Institute, REDDIE, More-EUROPA, Oncovalue, Real4Reg, RWE4Decisions, TEHDAS, QUANTUM, CORE-MD, REALM<sup>2 </sup>and projects under the ongoing call for proposals HORIZON-HLTH-2024-IND-06-08. It should also be aligned with the ambitions and guidelines set out for the European Health Data Space (EHDS)<sup>3</sup>.</p><p><sup>1</sup> <sub> Arlett P. et al. Real-World Evidence in EU Medicines Regulation: Enabling Use and Establishing Value. Clinical Pharmacology &amp; Therapeutics 2021 <a href=\"http://ascpt.onlinelibrary.wiley.com/doi/10.1002/cpt.2479\">https://doi.org/10.1002/cpt.2479</a></sub> </p><p><sup>2</sup> <sub><a href=\"http://www.getreal-institute.org/\">www.getreal-institute.org</a>, <a href=\"http://www.reddie-diabetes.eu/\">www.reddie-diabetes.eu</a>, <a href=\"http://cordis.europa.eu/project/id/101095479\">cordis.europa.eu/project/id/101095479</a>, <a href=\"http://oncovalue.org/\">oncovalue.org</a>, <a href=\"http://www.real4reg.eu/\">www.real4reg.eu</a>, <a href=\"http://realm-ai.eu/\">realm-ai.eu</a></sub></p><p><sup>3 </sup><a href=\"http://health.ec.europa.eu/ehealth-digital-health-and-care/european-health-data-space_en\"><sub>health.ec.europa.eu/ehealth-digital-health-and-care/european-health-data-space_en</sub></a></p>\n<SPAN class=\"topicdescriptionkind\">Expected Impact</SPAN>:<p>The action under this topic is expected to achieve the following impacts:</p><ul level=\"0\"><li>Improved access to innovations that meet the increasingly diverse needs of patients and those of the healthcare systems.</li><li>Better informed decision-making at different levels of the healthcare system (authorities, organisations) using RWD/RWE that will in turn contribute to a better allocation of resources towards cost-effective innovations as well as representation of different patient populations and needs.</li><li>Faster entry to the market of cost-effective medicinal products and devices (including combinations) developed by industry or public not-for-profit developers, which could translate to a positive effect on their R&amp;I investments.</li> </ul>\n", "conditions": "<h1><span style=\"color: rgb(0, 0, 0);\"><span style=\"font-size: medium;\"><span style=\"font-family: Arial;\"><b><span lang=\"EN-US\" style=\"line-height: 115%;\">General conditions</span></b></span></span></span></h1>\r\n<p class=\"MsoNormal\">&nbsp;</p>\r\n<p class=\"MsoNormal\"><b><span lang=\"EN-US\" style=\"mso-ansi-language:EN-US\">1. Admissibility conditions:&nbsp;described in&nbsp;</span><a href=\"https://ec.europa.eu/info/funding-tenders/opportunities/docs/2021-2027/horizon/wp-call/2023-2024/wp-13-general-annexes_horizon-2023-2024_en.pdf\" target=\"_blank\">Annex A</a></b><b><span lang=\"EN-US\" style=\"mso-ansi-language:&#10;EN-US\">&nbsp;and&nbsp;</span><a href=\"https://ec.europa.eu/info/funding-tenders/opportunities/docs/2021-2027/horizon/wp-call/2023-2024/wp-13-general-annexes_horizon-2023-2024_en.pdf\" target=\"_blank\">Annex E</a></b><b><span lang=\"EN-US\" style=\"mso-ansi-language:&#10;EN-US\">&nbsp;of the Horizon Europe Work Programme General Annexes</span><o:p></o:p></b></p>\r\n<p>&nbsp;</p>\n<p><span style=\"color: rgb(0, 0, 0);\"><span style=\"font-size: small;\"><span style=\"font-family: Arial;\"><b><span lang=\"EN-US\">Proposal page limits and layout:</span></b><span lang=\"EN-US\"> described in Part B of the Application Form available in the Submission System</span></span></span></span>&nbsp;</p>\r\n<ul>\r\n    <li>at      stage 1 of a two-stage Call, the limit for RIA short proposals is 20      pages;<o:p></o:p></li>\r\n    <li>at      stage 2 of a two-stage Call, the limit for RIA full proposals is 50 pages.<o:p></o:p></li>\r\n</ul>\r\n<p>&nbsp;</p>\n<p><span style=\"color: rgb(0, 0, 0);\"><span style=\"font-size: small;\"><span style=\"font-family: Arial;\"><b><span lang=\"EN-US\">2. Eligible countries: </span></b><span lang=\"EN-US\">described in </span></span></span></span><span class=\"MsoHyperlink\"><span style=\"mso-bidi-font-family:Calibri;&#10;mso-bidi-theme-font:minor-latin\"><a href=\"https://ec.europa.eu/info/funding-tenders/opportunities/docs/2021-2027/horizon/wp-call/2023-2024/wp-13-general-annexes_horizon-2023-2024_en.pdf\" target=\"_blank\"><span style=\"font-size: small;\"><span style=\"font-family: Arial;\">Annex B</span></span></a></span></span><span style=\"font-size: small;\"><span style=\"font-family: Arial;\"><span lang=\"EN-US\"> </span></span></span><span style=\"color: rgb(0, 0, 0);\"><span style=\"font-size: small;\"><span style=\"font-family: Arial;\"><span lang=\"EN-US\">of the Work Programme General Annexes</span></span></span></span><span lang=\"EN-US\" style=\"mso-ansi-language:EN-US\"><o:p></o:p></span></p>\r\n<p><span style=\"color: rgb(0, 0, 0);\"><span style=\"font-size: small;\"><span style=\"font-family: Arial;\"><span lang=\"EN-US\">A number of non-EU/non-Associated Countries that are not automatically eligible for funding have made specific provisions for making funding available for their participants in Horizon Europe projects. See the information in the </span></span></span></span><span class=\"MsoHyperlink\"><span style=\"mso-bidi-font-family:Calibri;mso-bidi-theme-font:&#10;minor-latin\"><a href=\"https://ec.europa.eu/info/funding-tenders/opportunities/docs/2021-2027/horizon/guidance/programme-guide_horizon_en.pdf\"><span style=\"font-size: small;\"><span style=\"font-family: Arial;\">Horizon Europe Programme Guide</span></span></a></span></span><span style=\"font-size: small;\"><span style=\"font-family: Arial;\"><span lang=\"EN-US\">.</span></span></span></p>\n<p><span style=\"color: rgb(0, 0, 0);\"><span style=\"font-size: small;\"><span style=\"font-family: Arial;\"><b style=\"mso-bidi-font-weight:normal\"><span lang=\"EN-US\">3. Other eligibility conditions:</span></b><span lang=\"EN-US\"> described in </span></span></span></span><span class=\"MsoHyperlink\"><span style=\"mso-bidi-font-family:&#10;Calibri;mso-bidi-theme-font:minor-latin\"><a href=\"https://ec.europa.eu/info/funding-tenders/opportunities/docs/2021-2027/horizon/wp-call/2023-2024/wp-13-general-annexes_horizon-2023-2024_en.pdf\" target=\"_blank\"><span style=\"font-size: small;\"><span style=\"font-family: Arial;\">Annex B</span></span></a></span></span><span style=\"color: rgb(0, 0, 0);\"><span style=\"font-size: small;\"><span style=\"font-family: Arial;\"> <span lang=\"EN-US\">of the Work Programme General Annexes</span></span></span></span><span lang=\"EN-US\" style=\"mso-ansi-language:EN-US\">&nbsp;and in the ''Conditions of the Calls for proposals and Calls management rules'' section of the&nbsp;<a href=\"https://www.ihi.europa.eu/sites/default/files/uploads/Documents/About/AWP/WorkProgramme2024.pdf\">IHI JU Work Programme (WP)</a></span><o:p></o:p></p>\n<p><span style=\"color: rgb(0, 0, 0);\"><span style=\"font-size: small;\"><span style=\"font-family: Arial;\"><b>4. Financial and operational capacity and exclusion: </b>described in </span></span></span><span style=\"mso-bidi-font-weight:bold\"><a href=\"https://ec.europa.eu/info/funding-tenders/opportunities/docs/2021-2027/horizon/wp-call/2023-2024/wp-13-general-annexes_horizon-2023-2024_en.pdf\" target=\"_blank\"><span style=\"font-size: small;\"><span style=\"font-family: Arial;\">Annex C</span></span></a></span><span style=\"color: rgb(0, 0, 0);\"><span style=\"font-size: small;\"><span style=\"font-family: Arial;\"> of the Work Programme General Annexes</span></span></span></p>\n<p><span style=\"color: rgb(0, 0, 0);\"><span style=\"font-size: small;\"><span style=\"font-family: Arial;\"><b><span lang=\"FR-BE\">5.&nbsp;Evaluation and award:</span></b></span></span></span></p>\n<ul style=\"margin-top:0cm\" type=\"square\">\r\n    <li class=\"MsoNormal\">\r\n    <p><span style=\"color: rgb(0, 0, 0);\"><span style=\"font-size: small;\"><span style=\"font-family: Arial;\"><b><span lang=\"EN-US\">Award criteria, scoring and      thresholds</span></b><span lang=\"EN-US\"> are      described in </span></span></span></span><span class=\"MsoHyperlink\"><a href=\"https://ec.europa.eu/info/funding-tenders/opportunities/docs/2021-2027/horizon/wp-call/2023-2024/wp-13-general-annexes_horizon-2023-2024_en.pdf\" target=\"_blank\"><span style=\"font-size: small;\"><span style=\"font-family: Arial;\">Annex      D</span></span></a></span><span style=\"font-size: small;\"><span style=\"font-family: Arial;\"><span lang=\"EN-US\"> </span><span style=\"color: rgb(0, 0, 0);\"><span lang=\"EN-US\">of      the Work Programme General Annexes and&nbsp;</span></span></span></span>in the ''Conditions of the      Calls for proposals and Calls management rules'' section of the&nbsp;<a href=\"https://www.ihi.europa.eu/sites/default/files/uploads/Documents/About/AWP/WorkProgramme2024.pdf\">IHI      JU Work Programme (WP)</a></p>\r\n    <o:p></o:p></li>\r\n</ul>\n<ul style=\"margin-top:0cm\" type=\"square\">\r\n    <li class=\"MsoNormal\">\r\n    <p><span style=\"color: rgb(0, 0, 0);\"><span style=\"font-size: small;\"><span style=\"font-family: Arial;\"><b><span lang=\"EN-US\">Submission and evaluation      processes</span></b><span lang=\"EN-US\"> are      described in </span></span></span></span><span class=\"MsoHyperlink\"><a href=\"https://ec.europa.eu/info/funding-tenders/opportunities/docs/2021-2027/horizon/wp-call/2023-2024/wp-13-general-annexes_horizon-2023-2024_en.pdf\" target=\"_blank\"><span style=\"font-size: small;\"><span style=\"font-family: Arial;\">Annex      F</span></span></a></span><span style=\"color: rgb(0, 0, 0);\"><span style=\"font-size: small;\"><span style=\"font-family: Arial;\"><span lang=\"EN-US\"> of      the Work Programme General Annexes and the </span></span></span></span><a href=\"https://ec.europa.eu/info/funding-tenders/opportunities/docs/2021-2027/common/guidance/om_en.pdf\"><span style=\"font-size: small;\"><span style=\"font-family: Arial;\">Online      Manual</span></span></a><span lang=\"EN-US\"><o:p></o:p></span></p>\r\n    </li>\r\n</ul>\n<ul style=\"margin-top:0cm\" type=\"square\">\r\n    <li class=\"MsoNormal\">\r\n    <p><span style=\"color: rgb(0, 0, 0);\"><span style=\"font-size: small;\"><span style=\"font-family: Arial;\"><b><span lang=\"EN-US\">Indicative timeline for      evaluation and grant agreement: </span></b><span lang=\"EN-US\">described in </span></span></span></span><span class=\"MsoHyperlink\"><a href=\"https://ec.europa.eu/info/funding-tenders/opportunities/docs/2021-2027/horizon/wp-call/2023-2024/wp-13-general-annexes_horizon-2023-2024_en.pdf\" target=\"_blank\"><span style=\"font-size: small;\"><span style=\"font-family: Arial;\">Annex      F</span></span></a></span><span style=\"color: rgb(0, 0, 0);\"><span style=\"font-size: small;\"><span style=\"font-family: Arial;\"><span lang=\"EN-US\"> of the Work Programme General Annexes</span></span></span></span><span lang=\"EN-US\"><o:p></o:p></span></p>\r\n    </li>\r\n</ul>\n<p><span style=\"color: rgb(0, 0, 0);\"><span style=\"font-size: small;\"><span style=\"font-family: Arial;\"><b style=\"mso-bidi-font-weight:normal\"><span lang=\"EN-US\">6. Legal and financial set-up of the grants: </span></b><span lang=\"EN-US\">described in </span></span></span></span><span class=\"MsoHyperlink\"><span style=\"mso-bidi-font-family:Calibri;mso-bidi-theme-font:&#10;minor-latin\"><a href=\"https://ec.europa.eu/info/funding-tenders/opportunities/docs/2021-2027/horizon/wp-call/2023-2024/wp-13-general-annexes_horizon-2023-2024_en.pdf\" target=\"_blank\"><span style=\"font-size: small;\"><span style=\"font-family: Arial;\">Annex G</span></span></a></span></span><span style=\"color: rgb(0, 0, 0);\"><span style=\"font-size: small;\"><span style=\"font-family: Arial;\"><span lang=\"EN-US\"> of the Work Programme General Annexes</span></span></span></span></p>\r\n<p>&nbsp;</p>\n<h1><span style=\"font-size: medium;\"><span style=\"font-family: Arial;\"><b><span lang=\"EN-US\" style=\"line-height: 115%;\">Specific conditions</span></b></span></span><b><span lang=\"EN-US\" style=\"font-size:12.0pt;mso-bidi-font-size:&#10;11.0pt;line-height:115%;mso-ansi-language:EN-US\"><o:p></o:p></span></b></h1>\r\n<p class=\"MsoNormal\"><span style=\"color: rgb(0, 0, 0);\"><span style=\"font-size: small;\"><span style=\"font-family: Arial;\"><b><span lang=\"EN-US\">7.&nbsp;</span></b></span></span></span><b><span lang=\"EN-US\" style=\"font-size:11.0pt;&#10;line-height:107%;font-family:&quot;Calibri&quot;,sans-serif;mso-ascii-theme-font:minor-latin;&#10;mso-fareast-font-family:Calibri;mso-fareast-theme-font:minor-latin;mso-hansi-theme-font:&#10;minor-latin;mso-bidi-font-family:&quot;Times New Roman&quot;;mso-bidi-theme-font:minor-bidi;&#10;mso-ansi-language:EN-US;mso-fareast-language:EN-US;mso-bidi-language:AR-SA\">Specific conditions:&nbsp;</span></b><span lang=\"EN-US\" style=\"font-size: 11pt; line-height: 107%; font-family: Calibri, sans-serif;\">described in the described in the ''Conditions of the Calls for proposals and Calls management rules&quot; section of the&nbsp;<a href=\"https://www.ihi.europa.eu/sites/default/files/uploads/Documents/About/AWP/WorkProgramme2024.pdf\">IHI JU Work Programme (WP)</a></span></p>\r\n<ul style=\"margin-top:0cm\" type=\"square\">\r\n    <li class=\"MsoNormal\"><span style=\"font-family: Arial, sans-serif; background-image: initial; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial;\">&nbsp;specific conditions on Availability, Accessibility and      Affordability (3A) <b>do not apply to this topic<o:p></o:p></b></span></li>\r\n</ul>\r\n<ul style=\"margin-top:0cm\" type=\"square\">\r\n    <li class=\"MsoNormal\"><span style=\"font-family: Arial, sans-serif; background-image: initial; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial;\">JU's right to object to transfer/exclusive licensing<o:p></o:p></span></li>\r\n</ul>\r\n<p class=\"MsoNormal\">&nbsp;</p>\r\n<p class=\"MsoNormal\"><o:p>&nbsp;</o:p></p>\r\n<p class=\"MsoNormal\"><span lang=\"EN-US\"><o:p></o:p></span></p>\n<h1><span style=\"font-size: medium;\"><b><span lang=\"EN-US\" style=\"line-height: 115%;\"><span style=\"font-family: Arial;\">Documents</span></span></b></span><b><span lang=\"EN-US\" style=\"font-size:12.0pt;mso-bidi-font-size:&#10;11.0pt;line-height:115%;mso-ansi-language:EN-US\"><o:p></o:p></span></b></h1>\r\n<p class=\"MsoNormal\" style=\"margin-bottom:0cm;margin-bottom:.0001pt\"><b><span style=\"mso-bidi-font-size:10.0pt;line-height:107%;&#10;mso-fareast-font-family:&quot;Times New Roman&quot;;mso-fareast-theme-font:minor-fareast\">Where relevant, templates of the reference documents and associated guidance can be found on the </span>IHI JU </b><a href=\"https://www.ihi.europa.eu/apply-funding/call-documents\"><b>website</b></a><span class=\"MsoHyperlink\"><b> </b></span><b><span style=\"mso-bidi-font-size:10.0pt;&#10;line-height:107%;mso-fareast-font-family:&quot;Times New Roman&quot;;mso-fareast-theme-font:&#10;minor-fareast\">. <o:p></o:p></span></b></p>\r\n<p class=\"MsoNormal\"><b><span style=\"mso-bidi-font-size:10.0pt;line-height:107%;&#10;mso-fareast-font-family:&quot;Times New Roman&quot;;mso-fareast-theme-font:minor-fareast\">Regarding the application forms for submitting proposals, the relevant templates and annexes are available to download in the submission system.</span><o:p></o:p></b></p>\r\n<p class=\"MsoNormal\"><b>The IHI JU 6<sup>th</sup>&nbsp;Call for proposals full topics text is available <a href=\"https://www.ihi.europa.eu/sites/default/files/uploads/Documents/Calls/IHI_Call6_CallText.pdf\" target=\"_blank\">here</a></b><o:p></o:p></p>\r\n<p class=\"MsoNormal\"><o:p>&nbsp;</o:p></p>\r\n<p class=\"MsoNormal\">&nbsp;<b>Evaluation form (single and two-stage Calls)</b><o:p></o:p></p>\r\n<p class=\"MsoNormal\">-&nbsp;<a href=\"https://www.ihi.europa.eu/sites/default/files/uploads/Documents/Calls/IHI_Evaluation_form_RIA_UpdateDec2023.pdf\">IHI JU Evaluation form for Research and Innovation Actions&nbsp;</a>(single and two-stage Calls)<o:p></o:p></p>\r\n<p class=\"MsoNormal\">&nbsp;&nbsp;<o:p></o:p></p>\r\n<p class=\"MsoNormal\"><b>Proposal Templates Part A and Part B (Research and Innovation Actions &ndash; stage one of two-stage procedure)&nbsp;</b><o:p></o:p></p>\r\n<p class=\"MsoNormal\">-&nbsp;Proposal template - Part A of the proposal is generated by the IT system in the submission environment (for more information see the HE Part A template&nbsp;<a href=\"https://ec.europa.eu/info/funding-tenders/opportunities/docs/2021-2027/horizon/temp-form/af/af_he-ria-ia-stage-1_en.pdf\">here</a>). In Part A of the proposal applicants insert general information on their proposal (e.g. proposal acronym), details on the participants and the overall proposal budget. Please note that&nbsp;<b>only</b>&nbsp;Part A of this template is applicable for this Call. For Part B, see point below.<o:p></o:p></p>\r\n<p class=\"MsoNormal\">-&nbsp;<a href=\"https://www.ihi.europa.eu/sites/default/files/IHI_Proposal_template_RIA_SP_PartB.pdf\">IHI JU Proposal template (RIA/SP) - Part B</a>&nbsp;<o:p></o:p><span style=\"font-family: eui-light, &quot;Helvetica Neue&quot;, Helvetica, sans-serif; font-size: 12.6px; background-color: rgb(198, 219, 239);\">&nbsp;</span><b style=\"font-family: eui-light, &quot;Helvetica Neue&quot;, Helvetica, sans-serif; font-size: 12.6px; background-color: rgb(198, 219, 239);\"><u><span lang=\"EN-IE\">(applicable to the first-stage of two-stage Calls)</span></u></b></p>\r\n<p class=\"MsoNormal\">-&nbsp;<a href=\"https://www.ihi.europa.eu/sites/default/files/uploads/Documents/Calls/IHI_Proposal_template_RIA_FP_PartB_UpdateDec2023.pdf\"><span lang=\"EN-IE\" style=\"mso-ansi-language:EN-IE\">IHI JU Proposal template (RIA/FP) - Part B</span></a>&nbsp;<b><u><span lang=\"EN-IE\" style=\"mso-ansi-language:EN-IE\">(applicable to the second stage of two-stage Calls)</span></u></b><o:p></o:p></p>\r\n<p class=\"MsoNormal\">&nbsp;&nbsp;<b>Proposal Annexes</b><o:p></o:p></p>\r\n<p class=\"MsoNormal\"><b>- Annex: Type of Participants</b><o:p></o:p></p>\r\n<p class=\"MsoNormal\">The&nbsp;<i>&ldquo;type of participants&rdquo;</i>&nbsp;is an IHI specific annex. <o:p></o:p></p>\r\n<p class=\"MsoNormal\">The excel template for:<o:p></o:p></p>\r\n<p class=\"MsoListParagraphCxSpFirst\" style=\"margin-left:11.3pt;mso-add-space:&#10;auto;text-indent:-11.3pt;mso-list:l0 level1 lfo1\"><!--[if !supportLists]--><span style=\"font-size:10.0pt;mso-bidi-font-size:11.0pt;line-height:107%;font-family:&#10;Wingdings;mso-fareast-font-family:Wingdings;mso-bidi-font-family:Wingdings\"><span style=\"mso-list:Ignore\">&sect;<span style=\"font:7.0pt &quot;Times New Roman&quot;\"> </span></span></span><!--[endif]-->short proposals (first stage of two-stage calls) can be found&nbsp;<a href=\"https://www.ihi.europa.eu/sites/default/files/uploads/Documents/Calls/IHI_Annex_Type_of_participants_Stage1.xlsx\">here</a>&nbsp;and <o:p></o:p></p>\r\n<p class=\"MsoListParagraphCxSpLast\" style=\"margin-left:11.3pt;mso-add-space:auto;&#10;text-indent:-11.3pt;mso-list:l0 level1 lfo1\"><!--[if !supportLists]--><span style=\"font-size:10.0pt;mso-bidi-font-size:11.0pt;line-height:107%;font-family:&#10;Wingdings;mso-fareast-font-family:Wingdings;mso-bidi-font-family:Wingdings\"><span style=\"mso-list:Ignore\">&sect;<span style=\"font:7.0pt &quot;Times New Roman&quot;\"> </span></span></span><!--[endif]-->full proposals (single-stage calls, and second stage of two-stage calls) can be found&nbsp;<a href=\"https://www.ihi.europa.eu/sites/default/files/IHI_Annex_Type_of_participants.xlsx\">here</a>&nbsp; <o:p></o:p></p>\r\n<p class=\"MsoNormal\">The instructions on how to fill in this template can be found&nbsp;<a href=\"https://www.ihi.europa.eu/sites/default/files/IHI_Annex_Type_of_participants_instrucctions.pdf\">here</a>.<o:p></o:p></p>\r\n<p class=\"MsoNormal\"><i>This is a compulsory annex, and it must be uploaded as a separate document in the submission system.</i><o:p></o:p></p>\r\n<p class=\"MsoNormal\">This annex is applicable to single-stage and in both stages of two-stage Calls.<o:p></o:p></p>\r\n<p class=\"MsoNormal\"><b><span lang=\"EN-IE\" style=\"mso-ansi-language:EN-IE\">- Annex: Declaration of in-kind contribution commitment</span></b><o:p></o:p></p>\r\n<p class=\"MsoNormal\">The &ldquo;<i>Declaration of in-kind contribution commitment&rdquo;</i>&nbsp;is an IHI specific annex and it is applicable to the single stage and second stage of two-stage Calls.<o:p></o:p></p>\r\n<p class=\"MsoNormal\">The word document template can be found&nbsp;<a href=\"https://www.ihi.europa.eu/sites/default/files/IHI_Annex_declaration_in_kind_contribution_commitment%20.pdf\">here</a><u>.</u><o:p></o:p></p>\r\n<p class=\"MsoNormal\"><i>This is a is a compulsory annex and it must be uploaded as a separate document in the submission system.</i><o:p></o:p></p>\r\n<p class=\"MsoNormal\"><b><span lang=\"EN-IE\" style=\"mso-ansi-language:EN-IE\">- Annex: In-kind contributions to additional activities (IKAA)</span></b><o:p></o:p></p>\r\n<p class=\"MsoNormal\">The &lsquo;<i>&rsquo;In-kind contributions to additional activities (IKAA)&rsquo;&rsquo;</i>&nbsp;is an IHI specific annex. The excel template can be found&nbsp;<a href=\"https://www.ihi.europa.eu/sites/default/files/uploads/Documents/Calls/IHI_Annex_declaration_in_kind_contribution_additional_activities_UpdateDec2023.xlsx\">here</a>&nbsp;and the instructions on how to fill in this template can be found&nbsp;<a href=\"https://www.ihi.europa.eu/sites/default/files/IHI_Annex_declaration_in_kind_contribution_additional_activities_instructions.pdf\">here</a>.<o:p></o:p></p>\r\n<p class=\"MsoNormal\"><i>This is an optional annex and</i><em>&nbsp;</em><o:p></o:p><em>it is applicable to the single stage and second stage of two-stage Calls.</em></p>\r\n<p class=\"MsoNormal\"><b><span lang=\"EN-IE\" style=\"mso-ansi-language:EN-IE\">- Annex: Essential information for clinical studies</span></b><o:p></o:p></p>\r\n<p class=\"MsoNormal\">The information on clinical studies is a Horizon Europe annex.<o:p></o:p></p>\r\n<p class=\"MsoNormal\"><i>This is a is a compulsory annex and it must be uploaded as a separate document in the submission system.</i><o:p></o:p></p>\r\n<p class=\"MsoNormal\">If your proposal does not include clinical studies, <u>please upload a statement declaring your proposal does not include clinical studies.</u><o:p></o:p></p>\r\n<p class=\"MsoNormal\">The information on clinical studies annex can be found&nbsp;<a href=\"https://ec.europa.eu/info/funding-tenders/opportunities/docs/2021-2027/horizon/temp-form/af/information-on-clinical-studies_he_en.docx\">here</a>:<o:p></o:p></p>\r\n<p class=\"MsoNormal\"><i>The annex&nbsp;</i><em>is applicable to the single stage and second stage of two-stage Calls<span lang=\"EN-IE\" style=\"mso-ansi-language:EN-IE\">.</span></em><o:p></o:p></p>\r\n<p class=\"MsoNormal\"><b><span lang=\"EN-IE\" style=\"mso-ansi-language:EN-IE\">- Annex: Ethics</span></b><o:p></o:p></p>\r\n<p class=\"MsoNormal\">This is a HE annex. Ethics self-assessment should be included in proposal part A. However, in Calls where several serious ethics issues are expected, the characters limit in this section of proposal part A may not be sufficient for participants to give all necessary information. In those cases, participants may include additional information in an annex to proposal part B.&nbsp;<o:p></o:p></p>\r\n<p class=\"MsoNormal\"><i>This is an optional annex and&nbsp;</i><em>it is applicable to the single stage and second stage of two-stage Calls.</em><o:p></o:p></p>\r\n<p class=\"MsoNormal\"><b><span lang=\"EN-IE\" style=\"mso-ansi-language:EN-IE\">- Annex to the budget for the Full Proposal&nbsp;</span></b><o:p></o:p></p>\r\n<p class=\"MsoNormal\"><i>This is a compulsory&nbsp;</i><a href=\"https://www.ihi.europa.eu/sites/default/files/uploads/Documents/Calls/Annex_Budget_for_full_Proposal_TWO_stage_call_UpdateDec2023.xlsx\"><i>Annex</i></a><u>,</u>&nbsp;which complements the budget figures already included in the proposal budget in PART A. Its purpose is to correctly guide the consortium in providing IHI-specific budget items (e.g. IKOP, IKAA, FC PAID, FC RECEIVED, etc.) and to comply with IHI additional eligibility criteria (e.g. 45% industry contribution).<o:p></o:p></p>\r\n<p class=\"MsoNormal\"><i>The annex is applicable to the</i>&nbsp;<em>single stage and second stage of two-stage Calls</em></p>\r\n<p class=\"MsoNormal\">&nbsp;&nbsp;<b>Model Grant Agreement (MGA)</b><o:p></o:p></p>\r\n<p class=\"MsoNormal\">&nbsp;-&nbsp;<a href=\"https://ec.europa.eu/info/funding-tenders/opportunities/docs/2021-2027/common/agr-contr/general-mga_horizon-euratom_en.pdf\">HE&nbsp;General MGA v1.0</a><o:p></o:p></p>\r\n<p>&nbsp;</p>\n<h2><span style=\"color: rgb(0, 0, 0);\"><span style=\"font-size: small;\"><span style=\"font-family: Arial;\"><b><span lang=\"EN-US\">Additional documents:</span></b></span></span></span><b><span lang=\"EN-US\"><o:p></o:p></span></b></h2>\r\n<p class=\"MsoNormal\"><b><span lang=\"EN-US\">Additional documents:</span><o:p></o:p></b></p>\r\n<p class=\"MsoNormal\">-&nbsp;<a href=\"https://eur-lex.europa.eu/eli/reg/2021/2085\">Council Regulation (EU) 2021/2085 of 19 November 2021 establishing the Joint Undertakings under Horizon Europe and repealing Regulations (EC) No 219/2007, (EU) No 557/2014, (EU) No 558/2014, (EU) No 559/2014, (EU) No 560/2014, (EU) No 561/2014 and (EU) No 642/2014</a>&nbsp;&nbsp;(in short Single Basic Act &lsquo;SBA&rsquo; or Council Regulation (EU) 2021/2085).<o:p></o:p></p>\r\n<p class=\"MsoNormal\">-&nbsp;<span lang=\"EN-US\"><a href=\"https://www.ihi.europa.eu/sites/default/files/uploads/Documents/About/AWP/WorkProgramme2024.pdf\">IHI JU Work Programme (WP)</a></span>&nbsp;<o:p></o:p></p>\r\n<p class=\"MsoNormal\">-&nbsp;<a href=\"https://www.ihi.europa.eu/sites/default/files/flmngr/IHI_Strategic_Research_and_Innovation_Agenda_3.pdf\">Strategic Research and Innovation Agenda (SRIA)</a><o:p></o:p></p>\r\n<p class=\"MsoNormal\">-&nbsp;<a href=\"https://www.ihi.europa.eu/sites/default/files/IHI_Guide_for_Applicants.pdf\" target=\"_blank\">IHI JU Guide for Applicants</a><o:p></o:p></p>\r\n<p class=\"MsoNormal\">-&nbsp;<a href=\"https://www.ihi.europa.eu/sites/default/files/uploads/Documents/Calls/Call_FAQs.pdf\" target=\"_blank\">IHI&nbsp;JU&nbsp;FAQs</a><o:p></o:p></p>\r\n<p class=\"MsoNormal\"><b>Horizon Europe Reference Documents</b><o:p></o:p></p>\r\n<p class=\"MsoNormal\"><a href=\"https://ec.europa.eu/info/funding-tenders/opportunities/docs/2021-2027/horizon/wp-call/2023-2024/wp-1-general-introduction_horizon-2023-2024_en.pdf\" target=\"_blank\">HE Main Work Programme 2023&ndash;2024 &ndash; 1. General Introduction</a><o:p></o:p></p>\r\n<p class=\"MsoNormal\"><a href=\"https://ec.europa.eu/info/funding-tenders/opportunities/docs/2021-2027/horizon/wp-call/2023-2024/wp-4-health_horizon-2023-2024_en.pdf\" target=\"_blank\">HE Main Work Programme 2023&ndash;2024 &ndash; 4. Health</a><o:p></o:p></p>\r\n<p class=\"MsoNormal\"><a href=\"https://ec.europa.eu/info/funding-tenders/opportunities/docs/2021-2027/horizon/wp-call/2023-2024/wp-12-missions_horizon-2023-2024_en.pdf\" target=\"_blank\">HE Main Work Programme 2023&ndash;2024 &ndash; 12. Missions</a><o:p></o:p></p>\r\n<p class=\"MsoNormal\"><a href=\"https://ec.europa.eu/info/funding-tenders/opportunities/docs/2021-2027/horizon/wp-call/2023-2024/wp-13-general-annexes_horizon-2023-2024_en.pdf\" target=\"_blank\">HE Main Work Programme 2023&ndash;2024 &ndash; 13. General Annexes</a><o:p></o:p></p>\r\n<p class=\"MsoNormal\"><a href=\"https://ec.europa.eu/info/funding-tenders/opportunities/docs/2021-2027/horizon/guidance/programme-guide_horizon_en.pdf\">HE Programme Guide</a><o:p></o:p></p>\r\n<p class=\"MsoNormal\"><a href=\"https://eur-lex.europa.eu/legal-content/EN/ALL/?uri=CELEX:32021R0695\" target=\"_blank\">HE Framework Programme and Rules for Participation Regulation 2021/695</a><o:p></o:p></p>\r\n<p class=\"MsoNormal\"><span lang=\"EN-US\"><a href=\"https://eur-lex.europa.eu/legal-content/EN/ALL/?uri=CELEX:32021D0764\" target=\"_blank\">HE Specific Programme Decision 2021/764</a></span><o:p></o:p></p>\r\n<p class=\"MsoNormal\"><a href=\"https://eur-lex.europa.eu/legal-content/EN/ALL/?uri=CELEX:32018R1046&amp;qid=1535046024012\"><span lang=\"EN-US\">EU Financial Regulation</span></a><o:p></o:p></p>\r\n<p class=\"MsoNormal\"><a href=\"https://ec.europa.eu/info/funding-tenders/opportunities/docs/2021-2027/common/guidance/rules-lev-lear-fca_en.pdf\">Rules for Legal Entity Validation, LEAR Appointment and Financial Capacity Assessment</a><o:p></o:p></p>\r\n<p class=\"MsoNormal\"><a href=\"https://ec.europa.eu/info/funding-tenders/opportunities/docs/2021-2027/common/guidance/aga_en.pdf\"><span lang=\"EN-US\">EU Grants AGA&nbsp;</span>&mdash; Annotated Model Grant Agreement</a><o:p></o:p></p>\r\n<p class=\"MsoNormal\"><a href=\"https://ec.europa.eu/info/funding-tenders/opportunities/docs/2021-2027/common/guidance/om_en.pdf\"><span lang=\"EN-US\">Funding &amp; Tenders Portal Online Manual</span></a><o:p></o:p></p>\r\n<p class=\"MsoNormal\"><a href=\"https://ec.europa.eu/info/funding-tenders/opportunities/docs/2021-2027/common/ftp/tc_en.pdf\">Funding &amp; Tenders Portal Terms and Conditions</a><o:p></o:p></p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom:0cm;margin-bottom:.0001pt\"><span style=\"font-size:11.0pt;line-height:107%;font-family:&quot;Calibri&quot;,sans-serif;&#10;mso-ascii-theme-font:minor-latin;mso-fareast-font-family:Calibri;mso-fareast-theme-font:&#10;minor-latin;mso-hansi-theme-font:minor-latin;mso-bidi-font-family:&quot;Times New Roman&quot;;&#10;mso-bidi-theme-font:minor-bidi;mso-ansi-language:EN-GB;mso-fareast-language:&#10;EN-US;mso-bidi-language:AR-SA\"><a href=\"https://ec.europa.eu/info/funding-tenders/opportunities/docs/2021-2027/common/ftp/privacy-statement_en.pdf\">Funding &amp; Tenders Portal Privacy Statement</a></span></p>", "supportInfo": "<p style=\"box-sizing: border-box; border: 0px; font-variant-numeric: inherit; font-variant-east-asian: inherit; font-variant-alternates: inherit; font-variant-position: inherit; font-stretch: inherit; line-height: inherit; font-family: Arial, &quot;Helvetica Neue&quot;, Helvetica, sans-serif; font-optical-sizing: inherit; font-kerning: inherit; font-feature-settings: inherit; font-variation-settings: inherit; font-size: 14px; margin: 0px 0px 1rem; padding: 0px; color: rgb(51, 51, 51);\">Please read carefully all provisions below before the preparation of your application.</p>\r\n<p>&nbsp;</p>\r\n<div style=\"box-sizing: border-box; border: 0px; font-variant-numeric: inherit; font-variant-east-asian: inherit; font-variant-alternates: inherit; font-variant-position: inherit; font-stretch: inherit; line-height: inherit; font-family: Arial, &quot;Helvetica Neue&quot;, Helvetica, sans-serif; font-optical-sizing: inherit; font-kerning: inherit; font-feature-settings: inherit; font-variation-settings: inherit; font-size: 14px; margin: 0px; padding: 0px; color: rgb(51, 51, 51);\">\r\n<p class=\"MsoNormal\" style=\"box-sizing: border-box; border: 0px; font-style: inherit; font-variant: inherit; font-weight: inherit; font-stretch: inherit; line-height: inherit; font-family: inherit; font-optical-sizing: inherit; font-kerning: inherit; font-feature-settings: inherit; font-variation-settings: inherit; font-size: var(--eui-font-size); margin-top: var(--eui-spacing); margin-right: 0px; margin-bottom: 1rem; margin-left: 0px; padding: 0px;\"><span style=\"box-sizing: border-box; border: 0px; font-style: inherit; font-variant: inherit; font-weight: inherit; font-stretch: inherit; line-height: inherit; font-family: inherit; font-optical-sizing: inherit; font-kerning: inherit; font-feature-settings: inherit; font-variation-settings: inherit; margin: 0px; padding: 0px;\">All the information concerning the IHI JU Calls is also published on the&nbsp;</span><a href=\"https://www.ihi.europa.eu/apply-funding/call-documents\" style=\"box-sizing: border-box; border: 0px; font-style: inherit; font-variant: inherit; font-weight: inherit; font-stretch: inherit; line-height: inherit; font-family: inherit; font-optical-sizing: inherit; font-kerning: inherit; font-feature-settings: inherit; font-variation-settings: inherit; margin: 0px; padding: 0px; touch-action: manipulation; cursor: pointer; background-color: initial; text-decoration-line: none;\" target=\"_blank\">IHI JU website</a><span style=\"box-sizing: border-box; border: 0px; font-style: inherit; font-variant: inherit; font-weight: inherit; font-stretch: inherit; line-height: inherit; font-family: inherit; font-optical-sizing: inherit; font-kerning: inherit; font-feature-settings: inherit; font-variation-settings: inherit; margin: 0px; padding: 0px;\">.&nbsp;</span><span style=\"box-sizing: border-box; border: 0px; font-style: inherit; font-variant: inherit; font-weight: inherit; font-stretch: inherit; line-height: inherit; font-family: inherit; font-optical-sizing: inherit; font-kerning: inherit; font-feature-settings: inherit; font-variation-settings: inherit; margin: 0px; padding: 0px;\">&nbsp;&nbsp;</span></p>\r\n<p class=\"MsoNormal\" style=\"box-sizing: border-box; border: 0px; font-style: inherit; font-variant: inherit; font-weight: inherit; font-stretch: inherit; line-height: inherit; font-family: inherit; font-optical-sizing: inherit; font-kerning: inherit; font-feature-settings: inherit; font-variation-settings: inherit; font-size: var(--eui-font-size); margin-top: var(--eui-spacing); margin-right: 0px; margin-bottom: 1rem; margin-left: 0px; padding: 0px;\"><span style=\"box-sizing: border-box; border: 0px; font-style: inherit; font-variant: inherit; font-weight: inherit; font-stretch: inherit; line-height: inherit; font-family: inherit; font-optical-sizing: inherit; font-kerning: inherit; font-feature-settings: inherit; font-variation-settings: inherit; margin: 0px; padding: 0px;\">All the questions pertaining to the IHI JU Calls are to be addressed to&nbsp;</span><a href=\"mailto:infodesk@ihi.europa.eu\" style=\"box-sizing: border-box; border: 0px; font-style: inherit; font-variant: inherit; font-weight: inherit; font-stretch: inherit; line-height: inherit; font-family: inherit; font-optical-sizing: inherit; font-kerning: inherit; font-feature-settings: inherit; font-variation-settings: inherit; margin: 0px; padding: 0px; touch-action: manipulation; cursor: pointer; background-color: initial; text-decoration-line: none;\">infodesk@ihi.europa.eu</a><span style=\"box-sizing: border-box; border: 0px; font-style: inherit; font-variant: inherit; font-weight: inherit; font-stretch: inherit; line-height: inherit; font-family: inherit; font-optical-sizing: inherit; font-kerning: inherit; font-feature-settings: inherit; font-variation-settings: inherit; margin: 0px; padding: 0px;\">.</span></p>\r\n</div>\r\n<p><strong><span style=\"font-size:9.0pt;font-family:&quot;Arial&quot;,sans-serif;&#10;font-weight:normal;mso-bidi-font-weight:bold\"><b><a href=\"https://ec.europa.eu/info/funding-tenders/opportunities/docs/2021-2027/common/guidance/om_en.pdf\" target=\"_blank\">Online Manual</a>&nbsp;</b></span></strong><span style=\"font-size: 9pt; font-family: Arial, sans-serif;\">is your guide on the procedures from proposal submission to managing your grant.<o:p></o:p></span></p>\r\n<p><a href=\"https://ec.europa.eu/info/funding-tenders/opportunities/docs/2021-2027/horizon/guidance/programme-guide_horizon_en.pdf\" target=\"_blank\"><b><span style=\"font-size:9.0pt;font-family:&quot;Arial&quot;,sans-serif\">Horizon Europe Programme Guide</span></b></a><strong><span style=\"font-size: 9pt; font-family: Arial, sans-serif;\">&nbsp;</span></strong><strong><span style=\"font-size: 9pt; font-family: Arial, sans-serif; font-weight: normal;\">contains the detailed guidance to the structure, budget and political priorities of Horizon Europe.</span></strong><span style=\"font-size: 9pt; font-family: Arial, sans-serif;\"><o:p></o:p></span></p>\r\n<p><span class=\"MsoHyperlink\"><b><span style=\"font-size:9.0pt;font-family:&quot;Arial&quot;,sans-serif\"><a href=\"https://ec.europa.eu/info/funding-tenders/opportunities/portal/screen/support/faq;type=undefined;categories=;programme=H2020;actions=;keyword=\" target=\"_blank\">Funding &amp; Tenders Portal FAQ</a></span></b></span><span style=\"font-size: 9pt; font-family: Arial, sans-serif;\">&nbsp;&ndash; find the answers to most frequently asked questions on submission of proposals, evaluation and grant management.<o:p></o:p></span></p>\r\n<p><span class=\"MsoHyperlink\"><b><span style=\"font-size:9.0pt;font-family:&quot;Arial&quot;,sans-serif\"><a href=\"https://ec.europa.eu/info/research-and-innovation/contact/research-enquiry-service_en\" target=\"_blank\">Research Enquiry Service</a></span>&nbsp;</b></span><span style=\"font-size: 9pt; font-family: Arial, sans-serif;\">&ndash; ask questions about any aspect of European research in general and the EU Research Framework Programmes in particular.</span></p>\r\n<p><span style=\"font-size: 9pt; font-family: Arial, sans-serif;\"><o:p></o:p></span></p>\r\n<p><b><span style=\"font-size: 9pt; font-family: Arial, sans-serif;\"><a href=\"https://ec.europa.eu/info/funding-tenders/opportunities/portal/screen/support/ncp\" target=\"_blank\">National Contact Points (NCPs)</a>&nbsp;</span></b><span style=\"font-size: 9pt; font-family: Arial, sans-serif;\">&ndash; get guidance, practical information and assistance on participation in Horizon Europe. There are also NCPs in many non-EU and non-associated countries (&lsquo;third-countries&rsquo;).<b><o:p></o:p></b></span></p>\r\n<p><a href=\"https://een.ec.europa.eu/\" target=\"_blank\"><b><span style=\"font-size:9.0pt;font-family:&quot;Arial&quot;,sans-serif\">Enterprise Europe Network</span></b></a><strong><span style=\"font-size:9.0pt;font-family:&quot;Arial&quot;,sans-serif;&#10;color:#003366\">&nbsp;</span></strong><span style=\"font-size: 9pt; font-family: Arial, sans-serif;\">&ndash; contact your EEN national contact for advice to businesses with special focus on SMEs. The support includes guidance on the EU research funding.<o:p></o:p></span></p>\r\n<p><span class=\"MsoHyperlink\"><b><span style=\"font-size:9.0pt;font-family:&quot;Arial&quot;,sans-serif\"><a href=\"https://ec.europa.eu/info/funding-tenders/opportunities/portal/screen/support/helpdesks/contact-form\" target=\"_blank\">IT Helpdesk</a></span></b>&nbsp;</span><span style=\"font-size: 9pt; font-family: Arial, sans-serif;\">&ndash;&nbsp;contact the Funding &amp; Tenders Portal IT helpdesk for questions such as forgotten passwords, access rights and roles, technical aspects of submission of proposals, etc.<o:p></o:p></span></p>\r\n<p><span class=\"MsoHyperlink\"><b><span style=\"font-size:9.0pt;font-family:&quot;Arial&quot;,sans-serif\"><a href=\"https://www.iprhelpdesk.eu/\" target=\"_blank\">European IPR Helpdesk</a></span></b></span><span style=\"font-size: 9pt; font-family: Arial, sans-serif;\">&nbsp;assists you on intellectual property issues.<br />\r\n<br />\r\n</span><b><a href=\"mailto:research@cencenelec.eu\" target=\"_blank\">CEN-CENELEC Research Helpdesk</a> and <a href=\"https://www.etsi.org/research/helpdesk\" target=\"_blank\">ETSI Research Helpdesk</a></b>&nbsp;<span style=\"font-family: Arial, sans-serif;\">&ndash;&nbsp;</span>the European Standards Organisations&nbsp;advise you how to tackle standardisation in your project proposal.&nbsp;&nbsp;</p>\r\n<p class=\"MsoNormal\" style=\"margin-left:36.0pt\"><o:p></o:p></p>\r\n<p><span class=\"MsoHyperlink\"><b><span style=\"font-size:9.0pt;font-family:&quot;Arial&quot;,sans-serif\"><a href=\"https://euraxess.ec.europa.eu/sites/default/files/am509774cee_en_e4.pdf\" target=\"_blank\">The European Charter for Researchers and the Code of Conduct for their recruitment</a></span></b></span><span style=\"font-size:&#10;9.0pt;font-family:&quot;Arial&quot;,sans-serif;color:#003366\"> </span><strong><span style=\"font-size:9.0pt;font-family:&quot;Arial&quot;,sans-serif;color:#003366;font-weight:&#10;normal;mso-bidi-font-weight:bold\">&ndash; consult the general principles and requirements specifying the roles, responsibilities and entitlements of researchers, employers and funders of researchers.</span></strong><b><span style=\"font-size: 9pt; font-family: Arial, sans-serif;\"><o:p></o:p></span></b></p>\r\n<p><span class=\"MsoHyperlink\"><b><span style=\"font-size:9.0pt;font-family:&quot;Arial&quot;,sans-serif\"><a href=\"https://ec.europa.eu/info/funding-tenders/opportunities/portal/screen/how-to-participate/partner-search\" target=\"_blank\">Partner Search Services</a></span></b></span><span style=\"font-size: 9pt; font-family: Arial, sans-serif;\">&nbsp;help you find a partner organisation for your proposal.<o:p></o:p></span></p>\r\n<p>&nbsp;</p>", "sepTemplate": "<p>To access the Electronic Submission Service, please click on the submission-button next to the <strong>type of action</strong> and the <strong>type of model grant agreement</strong> that corresponds to your proposal. You will then be asked to confirm your choice, as it cannot be changed in the submission system. Upon confirmation, you will be linked to the correct entry point.</p>\r\n<p>To access existing draft proposals for this topic, please login to the Funding &amp; Tenders Portal and select the My Proposals page of the My Area section.</p>", "links": [{"callIdentifier": "HORIZON-JU-IHI-2024-06-two-stage", "status": "Closed", "criterionType": "SubFundingScheme", "criterionTypeDescription": "subfunding schemes", "criterionCode": "HORIZON-JU-RIA", "criterionDescription": "HORIZON JU Research and Innovation Actions", "url": "https://ec.europa.eu/research/participants/submission/manage/screen/submission/create-draft/34744?topic=HORIZON-JU-IHI-2024-06-02-two-stage", "startDate": "Jan 16, 2024 12:00:00 AM", "endDate": "Oct 10, 2024 5:00:00 PM", "mgaDescription": "HORIZON Action Grant Budget-Based", "mgaCode": "HORIZON-AG"}], "additionalDossiers": [], "infoPackDossiers": [], "callDetailsJSONItem": {"latestInfos": [{"approvalDate": "Jun 21, 2024 10:37:49 AM", "lastChangeDate": "Jun 21, 2024 10:37:49 AM", "content": "<div>An overview of the evaluation results of the first stage of IHI Call 6, can be found in the <a href=\"https://www.ihi.europa.eu/sites/default/files/uploads/Documents/Calls/FlashInfo_Call6_Stage1.pdf\" target=\"_blank\">Flash Call Info Report</a></div>"}, {"approvalDate": "Apr 17, 2024 11:01:36 AM", "lastChangeDate": "Apr 17, 2024 11:01:36 AM", "content": "<div>Call HORIZON-JU-IHI-2024-06-two-stage Stage 1 submission has closed as of 16th April 2024.</div>\r\n<div>&nbsp;</div>\r\n<div>16 proposals have been submitted in total.</div>\r\n<div>&nbsp;</div>\r\n<div>The breakdown per topic is:</div>\r\n<div>&nbsp;</div>\r\n<div>HORIZON-JU-IHI-2024-06-01: 9 proposals</div>\r\n<div>&nbsp;</div>\r\n<div>HORIZON-JU-IHI-2024-06-02: 7 proposals</div>"}, {"approvalDate": "Jan 16, 2024 12:00:03 AM", "lastChangeDate": "Jan 16, 2024 12:00:03 AM", "content": "The submission session is now available for: HORIZON-JU-IHI-2024-06-02-two-stage(HORIZON-JU-RIA), HORIZON-JU-IHI-2024-06-01-two-stage(HORIZON-JU-RIA)"}], "hasForthcomingTopics": false, "hasOpenTopics": false, "allClosedTopics": true}}}